Millie Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-30,866
Closed -$1.93M 67
2016
Q4
$1.93M Sell
30,866
-53
-0.2% -$3.23K 1.96% 20
2016
Q3
$1.95M Buy
30,919
+214
+0.7% +$13.9K 2.15% 19
2016
Q2
$1.9M Hold
30,705
2.01% 22
2016
Q1
$1.75M Buy
30,705
+290
+1% +$16.2K 1.88% 26
2015
Q4
$1.8M Sell
30,415
-512
-2% -$29.5K 1.88% 24
2015
Q3
$1.68M Sell
30,927
-222
-0.7% -$14.5K 1.53% 31
2015
Q2
$2.09M Sell
31,149
-4,251
-12% -$278K 1.93% 25
2015
Q1
$2.07M Buy
+35,400
New +$2.14M 1.93% 24

Other funds holding ABBV

Millie Capital Management's ABBV Position: Q1 2017 in Review

Millie Capital Management sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 30,866 shares — an estimated $1.93M sold.

Millie Capital Management first reported a position in ABBV in Q1 2015 and held it in 8 quarters. The position peaked at $2.09M in Q2 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Millie Capital Management reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
  • Millie Capital Management sold 30,866 AbbVie shares in Q1 2017, an estimated $1.93M.
  • Millie Capital Management first reported a position in AbbVie in Q1 2015 and held it in 8 quarters.
  • Millie Capital Management's AbbVie position peaked at $2.09M in Q2 2015.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Millie Capital Management's 13F filing for Q1 2017, filed 1 May 2017.